Ruth Exner
Vienna, 1090, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Characterization of HER2 Expression Levels, Including HER2-Ultralow, in a Retrospective Male Breast Cancer Cohort.
Journal: Life (Basel, Switzerland)
Published: April 28, 2026
HER2/CEP17 ratio predicts residual cancer burden after neoadjuvant dual HER2 blockade: real-world data in patients with primary HER2-amplified breast cancer.
Journal: Virchows Archiv : an international journal of pathology
Published: May 06, 2025
Comparing functional and genomic-based precision medicine in blood cancer patients.
Journal: HemaSphere
Published: February 20, 2025
Risk Assessment Using Gene Expression Profiling Correlates with Clinical Prognosis Estimation in Hormone Receptor-Positive/HER2-Negative Early Breast Cancer.
Journal: Breast care (Basel, Switzerland)
Published: September 27, 2024
Prognostic relevance of the neurological symptom burden in brain metastases from breast cancer.
Journal: British journal of cancer
Published: March 03, 2024
Emergence of immune-related adverse events correlates with pathological complete response in patients receiving pembrolizumab for early triple-negative breast cancer.
Journal: Oncoimmunology
Published: November 29, 2023
The Impact of Adjuvant Radiotherapy on Immediate Prepectoral Implant-Based Breast Reconstruction.
Journal: Aesthetic plastic surgery
Published: July 12, 2023
Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 17, 2023
Ptotic versus Nonptotic Breasts in Nipple-sparing Mastectomy and Immediate Prepectoral Breast Reconstruction.
Journal: Plastic and reconstructive surgery. Global open
Published: February 09, 2023
Prepectoral Versus Subpectoral Implant-Based Breast Reconstruction: A Systemic Review and Meta-analysis.
Journal: Annals of surgical oncology
Published: May 13, 2022
Tailored axillary surgery in patients with clinically node-positive breast cancer: Pre-planned feasibility substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101).
Journal: Breast (Edinburgh, Scotland)
Published: July 30, 2021
Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders.
Journal: Cancer discovery
Published: April 26, 2021
Last Updated: 09/26/2026